Stryker Corporation (SYK) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Stryker Corporation (SYK:NYSE), powered by AI.

Current Price
$310.58
P/E Ratio
36.6
Market Cap
118.7B
Sector
Healthcare
What is the Stryker Corporation stock price forecast?

Stryker Corporation is currently trading at $310.58. View real-time AI analysis on Alpha Lenz.

What is Stryker Corporation insider trading activity?

View the latest insider trading data for Stryker Corporation on Alpha Lenz.

What is Stryker Corporation's P/E ratio?

Stryker Corporation's P/E ratio is 36.6.

Stryker Corporation

NYSE · SYK
$310.58+2.64(+0.86%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Stryker Corporation's future dividend policy...
Alpha Chat Insight

Stryker Corporation trades at a P/E of 36.6 (premium valuation) with strong ROE of 15.1%. 3Y revenue CAGR of 10.8% highlights clear growth momentum.

Ask for details

Company Overview

Stryker Corporation is a global leader in the medical technology sector, specializing in the design, manufacture, and distribution of innovative healthcare products. The company operates through two primary segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. Its offerings include surgical equipment, advanced surgical navigation and endoscopic systems, patient handling and emergency medical equipment, as well as a range of neurotechnology products used for minimally invasive procedures such as stroke interventions and complex cranial surgeries. In orthopaedics, Stryker provides implants for hip and knee replacements, spinal injury therapies, and products for trauma and extremity surgeries. Serving customers in approximately 75 countries, Stryker supports hospitals, physicians, and healthcare facilities worldwide, impacting over 150 million patients annually. Founded in 1941 and headquartered in Portage, Michigan, the company holds over 14,000 patents and invests heavily in research and development, reinforcing its strong presence and influence within the global healthcare industry.

CEOMr. Kevin A. Lobo
SectorHealthcare
IndustryMedical Devices
Employees53,000

Company Statistics

FY 2025

Profile

$118.70BMarket Cap
$25.12BRevenue
0.00Shares Out
53,000Employees

Margins

63.96%Gross
25.82%EBITDA
20.14%Operating
17.97%Pre-Tax
12.92%Net

Valuation

36.57P/E
5.29P/B
4.73EV/Sales
20.13EV/EBITDA
27.72P/FCF

Growth (CAGR)

10.83%Rev 3Yr
11.84%Rev 5Yr
18.48%Op Inc 3Yr
17.70%Op Inc 5Yr
11.24%Net Inc 3Yr
15.21%Net Inc 5Yr

Returns

7.15%ROA
15.08%ROE
11.28%ROIC

Financial Health

$4.01BCash & Cash Equivalents
$21.41BNet Debt
113.40%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Stryker Corporation (ticker: SYK) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 53,000 employees. Market cap is $118.7B.

The current price is $310.58 with a P/E ratio of 36.57x and P/B of 5.29x.

ROE is 15.08% and operating margin is 20.14%. Annual revenue is $25.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Stryker Corporation (SYK) Stock Forecast 2026 $310.58 — Price, Financials & Analyst Targets | Alpha Lenz